Finance

Lists
EXK:NYSE
Endeavour Silver Corp
8,68 USD
+0,93%
(+0,080) 1D
6-окт., 11:56:41 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EXK...
Open
8,69 USD
High
8,74 USD
Low
8,45 USD
Mkt. cap
2,57 млд
Avg. vol.
8,24 млн
Volume
2,44 млн
P/E ratio
49,02
52-wk high
15,15 USD
52-wk low
6,60 USD
EPS
0,18 USD
Beta
1,42
Shares outstanding
296,14 млн
No. of employees
2 миң
Open
8,69 USD
High
8,74 USD
Low
8,45 USD
Mkt. cap
2,57 млд
Avg. vol.
8,24 млн
Volume
2,44 млн
P/E ratio
49,02
52-wk high
15,15 USD
52-wk low
6,60 USD
EPS
0,18 USD
Beta
1,42
Shares outstanding
296,14 млн
No. of employees
2 миң
News stories
From web sources and news partners
StreetInsider
StreetInsider
·
12 мүнөт мурун
Paramount Skydance seals $110B Warner Bros deal as combined company hits NYSE
Seeking Alpha
Seeking Alpha
·
53 мүнөт мурун
25 stocks up more than +100% in 2026 as the S&P 500 hits record high
Breakingthenews.net
Breakingthenews.net
·
30 мүнөт мурун
US extends gains, Dow rises 400 pts
NBC News
NBC News
·
1 саат мурун
S&P 500 hits record high as Nvidia nears $6 trillion milestone
About Endeavour Silver Corp
CEODan Dickson
Employees2,16 миң
Founded1981
HeadquartersВанкувер, Бритиш Колумбия, Канада
Sector-
Websiteedrsilver.com
Analyst ratings
Based on 6 analysts giving stock ratings to EXK in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for EXK in the last 3 months.
Highest
Current 8,68 USD
17,53 USD (+101,85%)
Average
15,52 USD (+78,70%)
Lowest
14,00 USD (+61,20%)
Analyst
Recommendation
Action
Price target
Projected
Date
Cosmos Chiu
CIBC
Hold
Downgraded
20,00 CAD
+130,3%
09/22/2026
Unknown Analyst
National Bank
Buy
Maintained
25,00 CAD
+187,9%
09/21/2026
Kevin O'Halloran
BMO Capital
Buy
Maintained
21,50 CAD
+147,6%
08/24/2026
Soundarya Iyer
B. Riley Securities
Buy
Initiated
14,00 USD
+61,2%
08/03/2026
Jake Sekelsky
Alliance Global Partners
Buy
Reiterated
15,50 USD
+78,5%
07/31/2026
Heiko Ihle
H.C. Wainwright
Buy
Reiterated
17,00 USD
+95,7%
07/30/2026
Nick Giles
B. Riley Securities
Buy
Maintained
16,00 USD
+84,2%
05/12/2026
Last report
2026-ж., 30-июл.
Fiscal period
Q2 2026
EPS / Est. (CAD)
0,21 CAD / -
Revenue / Est. (CAD)
298,86 млн / 285,45 млн
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
142,83 млн
172,57 млн
209,70 млн
212,10 млн
Cost of goods sold
103,31 млн
101,10 млн
95,40 млн
112,40 млн
Cost of revenue
103,31 млн
101,10 млн
95,40 млн
112,40 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,54 млн
4,88 млн
4,70 млн
2,90 млн
Operating expense
37,71 млн
38,04 млн
30,60 млн
35,00 млн
Total operating expenses
141,02 млн
139,14 млн
126,00 млн
147,40 млн
Operating income
1,81 млн
33,44 млн
83,70 млн
64,70 млн
Other non operating income
-38,87 млн
-48,51 млн
-24,10 млн
23,30 млн
EBT including unusual items
-37,46 млн
-25,04 млн
85,90 млн
79,50 млн
EBT excluding unusual items
-37,45 млн
-17,72 млн
53,50 млн
82,90 млн
Income tax expense
4,50 млн
-1,26 млн
21,00 млн
13,00 млн
Effective tax rate
-12,01%
5,02%
24,45%
16,35%
Other operating expenses
-
1,20 млн
-
-
Net income
-41,96 млн
-23,78 млн
64,90 млн
66,50 млн
Net profit margin
-29,37%
-13,78%
30,95%
31,35%
Earnings per share
-0,01
-
-
-
Interest and investment income
-
1,10 млн
-
-
Interest expense
-997,00 миң
-3,75 млн
-5,80 млн
-5,70 млн
Net interest expenses
-997,00 миң
-2,65 млн
-5,80 млн
-5,70 млн
Depreciation and amortization charges
23,92 млн
24,87 млн
20,90 млн
25,70 млн
EBITDA
25,90 млн
59,62 млн
105,00 млн
90,80 млн
Gain or loss from assets sale
-51,00 миң
151,00 миң
-35,60 млн
-900,00 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору